Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas

Publisher： MDPI

E-ISSN： 1422-0067|19|3|739-739

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.19, Iss.3, 2018-03, pp. : 739-739

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trabectedin in Soft Tissue Sarcomas

By Petek Bradley J. Loggers Elizabeth T. Pollack Seth M. Jones Robin L.

Marine Drugs, Vol. 13, Iss. 2, 2015-02 ,pp. : 974-983

MDPI

Access to resources Recommend Favorite

Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future Directions

By Lee Dae-Won Lee Kyung-Hun Kim Jin Wook Keam Bhumsuk

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-07 ,pp. : 1074-1074

MDPI

Access to resources Recommend Favorite

Targeted α Therapies for the Treatment of Bone Metastases

By Zustovich Fable Barsanti Roberto

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2017-12 ,pp. : 74-74

MDPI

Access to resources Recommend Favorite

Combination of Trabectedin and Gemcitabine for Advanced Soft Tissue Sarcomas: Results of a Phase I Dose Escalating Trial of the German Interdisciplinary Sarcoma Group (GISG)

By Kasper Bernd Reichardt Peter Pink Daniel Sommer Michaela Mathew Monika Rauch Geraldine Hohenberger Peter

Marine Drugs, Vol. 13, Iss. 1, 2015-01 ,pp. : 379-388

MDPI

Access to resources Recommend Favorite

An Inflammatory Nucleus Pulposus Tissue Culture Model to Test Molecular Regenerative Therapies: Validation with Epigallocatechin 3-Gallate

By Krupkova Olga Hlavna Marian Amir Tahmasseb Julie Zvick Joel Kunz Dominik Ito Keita Ferguson Stephen J. Wuertz-Kozak Karin

International Journal of Molecular Sciences, Vol. 17, Iss. 10, 2016-09 ,pp. : 1640-1640

MDPI

Access to resources Recommend Favorite